To include your compound in the COVID-19 Resource Center, submit it here.

Bayer to develop Coagulin-B with Avigen

Bayer (DAX:BAYG) received exclusive worldwide marketing and distribution rights to

Read the full 104 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE